Cargando…
MON-498 Thyroseq V3 GC for Bethesda III and IV: An Institutional Experience
Background: Molecular testing of thyroid nodules classified as indeterminate on fine-needle aspiration (FNA) is used for patient management. ThyroSeq® v3 genomic classifier is a commercially available test that examines a wide spectrum of genomic alterations in a thyroid FNA sample based on algorith...
Autores principales: | Desai, Dimpi, Lepe, Marcos, Kim, Caroline S, Kobaly, Kristen, Baloch, Zubair Wahld, Mandel, Susan J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207932/ http://dx.doi.org/10.1210/jendso/bvaa046.1155 |
Ejemplares similares
-
MON-570 Clinical Utility of ThyroSeq v3 Genomic Classifier Test in Detecting Gene Fusions in Thyroid Nodules
por: Nikiforova, Marina, et al.
Publicado: (2019) -
MON-LB88 Positive Predictive Value of TP53 Variants in Bethesda III/IV Thyroid Fine-Needle Aspirates
por: Livhits, Masha J, et al.
Publicado: (2020) -
SAT571 When Two Is Too Few: Bethesda IV Pathology On Repeat Thyroid Fine Needle Aspiration
por: Godar, Cassandra M, et al.
Publicado: (2023) -
SUN-498 A Case of Thyroid Storm with Systemic Thromboembolism
por: Maung, Aye Chan, et al.
Publicado: (2020) -
SAT-498 Graves’-Associated Takotsubo Cardiomyopathy: An Uncommon Condition
por: Mortensen, Michael, et al.
Publicado: (2020)